Article
A Potential Beta-hydroxybutyrate Therapy for Duchenne Muscular Dystrophy in Disease Models
2025-10-19
Abstract excerpt
Duchenne muscular dystrophy (DMD) is a common and lethal muscular degenerative disorder caused by mutations in the Dystrophin gene. Patients with DMD suffer progressive motor and respiratory decline over time and exhibit mitochondria defects at the cellular level, contributing to their reduced life expectancy. Despite extensive efforts, effective treatments for DMD remain unavailable. This study aims to explore a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f39b4c8-6e0d-5ed3-b964-0d7466b31b91
- DOI
- 10.1101/2025.10.18.683257
